<VariationArchive VariationID="210843" VariationName="NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer)" VariationType="Duplication" Accession="VCV000210843" Version="27" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2015-10-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="207209" VariationID="210843">
      <GeneList>
        <Gene Symbol="DDX41" FullName="DEAD-box helicase 41" GeneID="51428" HGNC_ID="HGNC:18674" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177511577" stop="177516961" display_start="177511577" display_stop="177516961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176938577" stop="176943966" display_start="176938577" display_stop="176943966" Strand="-" />
          </Location>
          <OMIM>608170</OMIM>
          <Haploinsufficiency last_evaluated="2022-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DDX41">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DDX41">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer)</Name>
      <CanonicalSPDI>NC_000005.10:177515944:CATC:CATCCATC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q35.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177515944" stop="177515945" display_start="177515944" display_stop="177515945" variantLength="4" positionVCF="177515944" referenceAlleleVCF="T" alternateAlleleVCF="TCATC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176942945" stop="176942946" display_start="176942945" display_stop="176942946" variantLength="4" positionVCF="176942945" referenceAlleleVCF="T" alternateAlleleVCF="TCATC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.177515945_177515948dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.177515945_177515948dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.176942946_176942949dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.176942946_176942949dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046846.2" sequenceAccession="NG_046846" sequenceVersion="2" change="g.6014_6017dup">
            <Expression>NG_046846.2:g.6014_6017dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321732.2" sequenceAccession="NM_001321732" sequenceVersion="2" change="c.37_40dup">
            <Expression>NM_001321732.2:c.37_40dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308661.1" sequenceAccession="NP_001308661" sequenceVersion="1" change="p.Asp14delinsGlyTer">
            <Expression>NP_001308661.1:p.Asp14delinsGlyTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321830.2" sequenceAccession="NM_001321830" sequenceVersion="2" change="c.37_40dup">
            <Expression>NM_001321830.2:c.37_40dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308759.1" sequenceAccession="NP_001308759" sequenceVersion="1" change="p.Asp14delinsGlyTer">
            <Expression>NP_001308759.1:p.Asp14delinsGlyTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016222.4" sequenceAccession="NM_016222" sequenceVersion="4" change="c.415_418dup" MANESelect="true">
            <Expression>NM_016222.4:c.415_418dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057306.2" sequenceAccession="NP_057306" sequenceVersion="2" change="p.Asp140delinsGlyTer">
            <Expression>NP_057306.2:p.Asp140delinsGlyTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1386" sequenceAccession="LRG_1386">
            <Expression>LRG_1386:g.6014_6017dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1386t1" sequenceAccession="LRG_1386t1">
            <Expression>LRG_1386t1:c.415_418dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1386p1" sequenceAccession="LRG_1386p1" change="p.Asp140delinsGlyTer">
            <Expression>LRG_1386p1:p.Asp140delinsGlyTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016222.3" sequenceAccession="NM_016222" sequenceVersion="3" change="c.415_418dupGATG">
            <Expression>NM_016222.3:c.415_418dupGATG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016222.4" sequenceAccession="NM_016222" sequenceVersion="4" change="c.415_418dupGATG" MANESelect="true">
            <Expression>NM_016222.4:c.415_418dupGATG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA280919" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608170.0001" DB="OMIM" />
        <XRef Type="rs" ID="762890562" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00009" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00009" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer) AND Acute myeloid leukemia" Accession="RCV000193600" Version="8">
        <ClassifiedConditionList TraitSetID="6288">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer) AND DDX41-related hematologic malignancy predisposition syndrome" Accession="RCV000210272" Version="14">
        <ClassifiedConditionList TraitSetID="25690">
          <ClassifiedCondition DB="MedGen" ID="C4225174">DDX41-related hematologic malignancy predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-13" SubmissionCount="7">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer) AND not provided" Accession="RCV001008139" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-29" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-13" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2015-10-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25920683</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26712909</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27133828</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28547672</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30963592</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33585199</ID>
        </Citation>
        <DescriptionHistory Dated="2024-03-20">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic, risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-08-11">
          <Description>Pathogenic, risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-08-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25690" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34872" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">DDX41-related hematologic malignancy predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0014809" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MPLPF</ElementValue>
                <XRef Type="MIM" ID="616871" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">DDX41-associated familial myelodysplastic syndrome and acute myeloid leukemia (MDS/AML) is characterized by an increased risk of myeloid neoplasms, lymphoid neoplasms, adult-onset single- or multiple-lineage cytopenias (including aplastic anemia), and red blood cell macrocytosis. The most common myeloid neoplasms include MDS, AML, and therapy-related myeloid neoplasms. Chronic myelomonocytic leukemia, chronic myeloid leukemia, and myeloproliferative neoplasms are less common. Lymphoid neoplasms include non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia.</Attribute>
                <XRef ID="NBK574843" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17899" />
                <XRef ID="17899" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <XRef ID="488647" DB="Orphanet" />
              <XRef ID="C4225174" DB="MedGen" />
              <XRef ID="MONDO:0014809" DB="MONDO" />
              <XRef Type="MIM" ID="616871" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6288" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12757" />
                <XRef ID="12757" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Myeloid Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3896982" SubmissionDate="2021-11-01" DateLastUpdated="2022-10-01" DateCreated="2021-11-05">
        <ClinVarSubmissionID localKey="NM_016222.4:c.415_418dupGATG|MedGen:C4225174" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001999943" DateUpdated="2022-10-01" DateCreated="2021-11-05" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25920683</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28547672</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30963592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33585199</ID>
          </Citation>
          <Comment>Common recurrent germline variant, esp in persons of European ancestry [Polprasert et al 2015, Cheah et al 2017, Quesada et al 2019, Bannon et al 2021]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.4:c.415_418dupGATG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225174" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10604788</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4047984" SubmissionDate="2022-12-05" DateLastUpdated="2022-12-11" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer)|Acute myeloid leukemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002072044" DateUpdated="2022-12-11" DateCreated="2022-01-29" Type="SCV" Version="3" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the DDX41 gene demonstrated a four base pair deletion in exon 5, c.415_418dup. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon at position 2 in the new reading frame, p.Asp140Glyfs*2. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated DDX41 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a frequency of 0.017% in the European (non-Finnish) subpopulation. This pathogenic sequence change is a well described, recurrent variant that has previously been described in multiple individuals with DDX41-related myeloid malignancies (PMID: 25920683, 31484648, 26712909, 31400013, 30963592). This pathogenic sequence change is the most likely cause of this patient's phenotype.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.4:c.415_418dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
          <SubmissionName>SUB12333713</SubmissionName>
          <SubmissionName>SUB12366149</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4949244" SubmissionDate="2022-06-10" DateLastUpdated="2022-12-24" DateCreated="2022-06-16">
        <ClinVarSubmissionID localKey="NM_016222.3:c.415_418dup|OMIM:616871" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002526008" DateUpdated="2022-12-24" DateCreated="2022-06-16" Type="SCV" Version="2" SubmitterName="St. Jude Molecular Pathology, St. Jude Children's Research Hospital" OrgID="506672" OrganizationCategory="laboratory" OrgAbbreviation="SJCRH-MP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The DDX41 c.415_418dup (p.Asp140GlyfsTer2) change causes a frameshift and the creation of a premature stop codon. This change is predicted to cause protein truncation or absence of the protein due to nonsense-mediated decay. This variant has been reported in individuals with a personal and/or family history of acute myeloid leukemia and/or myelodysplastic syndrome (PMID: 25920683, 30963592, 31400013, 31484648, 33585199). This variant has a maximum subpopulation frequency of 0.017% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as pathogenic for familial myeloproliferative/lymphoproliferative neoplasms.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">St. Jude Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/0uggzi4w/st._jude_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.3:c.415_418dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11592018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="498767" SubmissionDate="2016-03-22" DateLastUpdated="2023-11-11" DateCreated="2016-03-26">
        <ClinVarSubmissionID localKey="608170.0001_MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO" title="DDX41, 4-BP INS, 419GATG_MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO" />
        <ClinVarAccession Accession="SCV000266343" DateUpdated="2023-11-11" DateCreated="2016-03-26" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 6 unrelated families with multiple types of familial myeloproliferative/lymphoproliferative neoplasms (MPLPF; 616871), Polprasert et al. (2015) identified a heterozygous germline 4-bp insertion (c.419insGATG) in the DDX41 gene, resulting in a frameshift (Asp140fs). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was not found in 200 in-house controls. It was found in 1 of 12,518 alleles in the Exome Sequencing Project database. About half of the patients also carried a somatic heterozygous c.1574G-A transition in the DDX41 gene, resulting in an arg525-to-his (R525H; 608170.0002) substitution at a conserved residue in an ATP binding domain, that was confirmed to be on the other allele. A heterozygous germline Asp140fs mutation was also found in 6 additional unrelated patients with sporadic myeloproliferative neoplasms. One of these patients also carried the somatic R525H mutation. These patients were part of a large cohort of 1,034 individuals with MDS/AML.</Attribute>
              <Citation>
                <ID Source="PubMed">25920683</ID>
              </Citation>
              <XRef DB="OMIM" ID="616871" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 4 patients from 3 unrelated families with MPLPF, Lewinsohn et al. (2016) identified a heterozygous germline 4-bp insertion (c.419insGATG, NM_016222.2) in the DDX41 gene, resulting in a frameshift and premature termination (Asp140fsTer2). One of the patients carried a somatic R525H mutation on the other allele. A fourth family (family UoC 127) with this mutation was reported in the supplementary material. There was evidence of incomplete penetrance in 2 of the families.</Attribute>
              <Citation>
                <ID Source="PubMed">26712909</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <Name>DDX41, 4-BP INS, 419GATG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 419GATG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608170.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5940052" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="2168667|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003252061" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26712909</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27133828</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25920683</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30963592</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp140Glyfs*2) in the DDX41 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DDX41 are known to be pathogenic (PMID: 26712909, 27133828). This variant is present in population databases (rs762890562, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with acute myeloid leukemia or myelodysplastic syndrome (PMID: 25920683, 30963592). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 210843). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.176942945_176942946insCATC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8977549" SubmissionDate="2024-03-19" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey=":Chr.5_176942945_176942945_T_TCATC|OMIM:616871" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004801445" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The DDX41 c.415_418dupGATG p.(Asp140GlyfsTer2) causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. This variant has been identified in individuals with a phenotype consistent with familial myeloproliferative/lymphoproliferative neoplasms (Polprasert et al. 2015; Lewinsohn et al. 2016). At least three individuals, ranging in age from 55 to 76 years, from these families also carried the variant but did not show signs of disease, though incomplete penetrance has been reported (Lewinsohn et al. 2016). The highest frequency of this allele in the Genome Aggregation Database is 0.000166 in the European (non-Finnish) population (version 2.1.1). Cheah et al. (2017) report that the c.415_418dupGATG variant is the most common DDX41 variant in Caucasian patients and suggest that it may be a founder variant in this population. Based on the available evidence, the c.415_418dupGATG p.(Asp140GlyfsTer2) variant is classified as likely pathogenic for susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="TCATC" referenceAllele="T" start="176942945" stop="176942945" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14324016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2919805" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2021-02-27">
        <ClinVarSubmissionID localKey="NM_016222.4:c.415_418dup|OMIM:616871" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001481241" DateUpdated="2024-06-17" DateCreated="2021-02-27" Type="SCV" Version="3" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.4:c.415_418dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-TexasKidsCanSeq</StudyName>
        <StudyDescription>The Texas KidsCanSeq Study is part of the Clinical Sequencing Evidence-Generating Research (CSER) consortium funded by the NIH National Human Genome Research Institute.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB9058000</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1139215" SubmissionDate="2017-07-06" DateLastUpdated="2017-07-30" DateCreated="2017-07-30">
        <ClinVarSubmissionID localKey="5:176942945:T" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000584085" DateUpdated="2017-07-30" DateCreated="2017-07-30" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">HA_assertions_20150911</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/zo9ynrar/ha_assertions_20150911.pdf</URL>
            <CitationText>HA_assertions_20150911.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">5:176942945:T:00305</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="TCATC" referenceAllele="T" start="176942945" stop="176942945" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-HudsonAlpha</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB2844653</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305891" SubmissionDate="2022-08-31" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:237956" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001167898" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26944477, 29372845, 26940275, 25920683, 26712909, 30963592, 31484648, 31400013, 27819178, 28637623, 28955657, 29790872, 26917736, 33778416, 33850299, 33585199)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:928653</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.2:c.415_418dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_126_20220831054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7329961" SubmissionDate="2023-04-25" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="NM_016222.3:c.415_418dupGATG|OMIM:616871" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003920855" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Clinical Genomics Labs, University Health Network" OrgID="508271" OrganizationCategory="laboratory" OrgAbbreviation="UHN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.3:c.415_418dupGATG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13174259</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5940052" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4047984" TraitType="Disease" MappingType="Name" MappingValue="Acute myeloid leukemia" MappingRef="Preferred">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305891" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3896982" TraitType="Disease" MappingType="XRef" MappingValue="C4225174" MappingRef="MedGen">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8977549" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7329961" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2919805" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="498767" TraitType="Disease" MappingType="Name" MappingValue="MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO" MappingRef="Preferred">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949244" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1139215" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

